My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

UFP Technologies, Inc. - Common Stock (NQ:UFPT)

226.40 +1.54 (+0.68%)

Streaming Delayed Price Updated: 10:21 AM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about UFP Technologies, Inc. - Common Stock

< Previous 1 2 3 4 Next >

1 Healthcare Stock to Own for Decades and 2 We Find Risky

August 22, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Retirement Stocks

Drug Development Inputs & Services Stocks Q2 Teardown: UFP Technologies (NASDAQ:UFPT) Vs The Rest

August 18, 2025

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including UFP Technologies (NASDAQ:UFPT) and its peers.

Via StockStory

Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

What to Expect from UFP Techs's Earnings ↗

August 01, 2025

Via Benzinga

An Overview of UFP Techs's Earnings ↗

May 05, 2025

Via Benzinga

UFPT Q2 Deep Dive: Medical Growth, Labor Headwinds, and M&A Shape Outlook

August 13, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 37.2% year on year to $151.2 million. Its non-GAAP profit of $2.50 per share...

Via StockStory

Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve.

Via StockStory

Topics Bonds Economy Stocks

UFP Technologies (UFPT) Q2 EPS Jumps 27% ↗

August 06, 2025

Via The Motley Fool

UFP Technologies (UFPT) Shares Skyrocket, What You Need To Know

August 05, 2025

Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 11.9% in the afternoon session after the company posted record second-quarter results and beat analyst profit expectations. The...

Via StockStory

Topics ETFs Stocks World Trade

UFP TECHNOLOGIES INC (NASDAQ:UFPT) Reports Record Q2 2025 Earnings with EPS Beat but Revenue Miss ↗

August 04, 2025

UFP Technologies reports record Q2 2025 earnings, beating EPS estimates but slightly missing revenue. Shares dip 1% amid mixed market reaction. Strong YoY growth in medical device demand.

Via Chartmill

UFP Technologies (NASDAQ:UFPT) Posts Q2 Sales In Line With Estimates

August 04, 2025

Via StockStory

UFP Technologies (UFPT) To Report Earnings Tomorrow: Here Is What To Expect

August 02, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results this Monday after market close. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence Economy World Trade

1 Small-Cap Stock Worth Your Attention and 2 Facing Headwinds

July 25, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Topics Emissions

10 Growth Stocks Down 10% or More to Buy Right Now ↗

July 17, 2025

Via The Motley Fool

Topics Artificial Intelligence Fraud World Trade

1 Volatile Stock with Exciting Potential and 2 to Question

July 17, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned...

Via StockStory

Topics ETFs Stocks World Trade

Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)

June 24, 2025

Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.

Via StockStory

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)

June 23, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks,...

Via StockStory

Topics Artificial Intelligence

1 Profitable Stock with Competitive Advantages and 2 to Think Twice About

June 20, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best

June 02, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how UFP Technologies (NASDAQ:UFPT)...

Via StockStory

3 Hyped Up Stocks Facing Headwinds

May 20, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

UFPT Q1 Earnings Call: Medical Segment Growth and Strategic Expansion Drive Outperformance

May 19, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) announced better-than-expected revenue in Q1 CY2025, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of $2.47 per share...

Via StockStory

UFP Technologies (NASDAQ:UFPT) Reports Upbeat Q1, Stock Soars

May 06, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 41.1% year on year to $148.1 million. Its non-GAAP profit of...

Via StockStory

UFP Technologies (UFPT) Q1 Earnings Report Preview: What To Look For

May 05, 2025

Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting earnings tomorrow before market hours. Here’s what to look for.

Via StockStory

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

April 10, 2025

A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,...

Via StockStory

Topics Economy Government World Trade

Why quality investors should have a look at UFP TECHNOLOGIES INC (NASDAQ:UFPT). ↗

April 01, 2025

A fundamental analysis of (NASDAQ:UFPT): Should you consider UFP TECHNOLOGIES INC (NASDAQ:UFPT) for quality investing?

Via Chartmill

This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

March 28, 2025

Via Benzinga

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 26, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest...

Via StockStory

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

March 25, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.

Via StockStory

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.